Better Therapeutics Analyst Ratings
Better Therapeutics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/10/2023 | 1116.22% | Chardan Capital | → $9 | Reiterates | Buy → Buy |
| 04/14/2023 | 575.68% | Lake Street | $6 → $5 | Maintains | Buy |
| 03/31/2023 | 1116.22% | Chardan Capital | $14 → $9 | Maintains | Buy |
| 11/15/2022 | 1791.89% | Chardan Capital | $17 → $14 | Maintains | Buy |
| 07/29/2022 | 2197.3% | Chardan Capital | $15 → $17 | Maintains | Buy |
| 03/16/2022 | 2332.43% | Chardan Capital | $17 → $18 | Maintains | Buy |
| 11/24/2021 | 2197.3% | Chardan Capital | → $17 | Initiates Coverage On | → Buy |
| 11/10/2021 | — | Cowen & Co. | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 08/10/2023 | 1116.22% | 查丹资本 | → 9 美元 | 重申 | 购买 → 购买 |
| 04/14/2023 | 575.68% | 湖街 | 6 美元 → 5 美元 | 维护 | 购买 |
| 03/31/2023 | 1116.22% | 查丹资本 | 14 美元 → 9 美元 | 维护 | 购买 |
| 11/15/2022 | 1791.89% | 查丹资本 | 17 美元 → 14 美元 | 维护 | 购买 |
| 2022 年 7 月 29 日 | 2197.3% | 查丹资本 | 15 美元 → 17 美元 | 维护 | 购买 |
| 2022 年 3 月 16 日 | 2332.43% | 查丹资本 | 17 美元 → 18 美元 | 维护 | 购买 |
| 11/24/2021 | 2197.3% | 查丹资本 | → 17 美元 | 启动覆盖开启 | → 购买 |
| 11/10/2021 | — | Cowen & Co. | 启动覆盖开启 | → 跑赢大盘 |
What is the target price for Better Therapeutics (BTTX)?
Better Therapeutics（BTTX）的目标价格是多少？
The latest price target for Better Therapeutics (NASDAQ: BTTX) was reported by Chardan Capital on August 10, 2023. The analyst firm set a price target for $9.00 expecting BTTX to rise to within 12 months (a possible 1116.22% upside). 4 analyst firms have reported ratings in the last year.
Chardan Capital于2023年8月10日公布了Better Therapeutics（纳斯达克股票代码：BTTX）的最新目标股价。这家分析公司将目标股价定为9.00美元，预计BTTX将在12个月内升至12个月内（可能上涨1116.22％）。去年有4家分析公司公布了评级。
What is the most recent analyst rating for Better Therapeutics (BTTX)?
分析师对Better Therapeutics（BTTX）的最新评级是多少？
The latest analyst rating for Better Therapeutics (NASDAQ: BTTX) was provided by Chardan Capital, and Better Therapeutics reiterated their buy rating.
Better Therapeutics（纳斯达克股票代码：BTTX）的最新分析师评级由Chardan Capital提供，Better Therapeutics重申了他们的买入评级。
When is the next analyst rating going to be posted or updated for Better Therapeutics (BTTX)?
Better Therapeutics（BTTX）的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Better Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Better Therapeutics was filed on August 10, 2023 so you should expect the next rating to be made available sometime around August 10, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Better Therapeutics的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月进行一次评级，因此每家公司每年应该获得4个评级。Better Therapeutics的最后一次评级是在2023年8月10日提交的，因此你应该预计下一个评级将在2024年8月10日左右公布。
Is the Analyst Rating Better Therapeutics (BTTX) correct?
分析师对 Better Therapeutics (BTTX) 的评级正确吗？
While ratings are subjective and will change, the latest Better Therapeutics (BTTX) rating was a reiterated with a price target of $0.00 to $9.00. The current price Better Therapeutics (BTTX) is trading at is $0.74, which is within the analyst's predicted range.
尽管评级是主观的，将会发生变化，但最新的Better Therapeutics（BTTX）评级得到了重申，目标股价为0.00美元至9.00美元。Better Therapeutics（BTTX）目前的交易价格为0.74美元，在分析师的预测区间内。
译文内容由第三方软件翻译。